Gyre Therapeutics (GYRE) Current Taxes (2022 - 2025)
Historic Current Taxes for Gyre Therapeutics (GYRE) over the last 4 years, with Q3 2025 value amounting to $2.6 million.
- Gyre Therapeutics' Current Taxes fell 689.66% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 689.66%. This contributed to the annual value of $2.8 million for FY2024, which is 4398.5% down from last year.
- Per Gyre Therapeutics' latest filing, its Current Taxes stood at $2.6 million for Q3 2025, which was down 689.66% from $1.1 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Current Taxes ranged from a high of $6.5 million in Q1 2024 and a low of $569000.0 during Q1 2025
- Over the past 4 years, Gyre Therapeutics' median Current Taxes value was $2.6 million (recorded in 2025), while the average stood at $2.9 million.
- As far as peak fluctuations go, Gyre Therapeutics' Current Taxes surged by 14055.21% in 2023, and later plummeted by 9120.56% in 2025.
- Quarter analysis of 4 years shows Gyre Therapeutics' Current Taxes stood at $2.1 million in 2022, then skyrocketed by 140.55% to $5.1 million in 2023, then crashed by 43.98% to $2.8 million in 2024, then dropped by 6.53% to $2.6 million in 2025.
- Its last three reported values are $2.6 million in Q3 2025, $1.1 million for Q2 2025, and $569000.0 during Q1 2025.